Literature DB >> 21596516

Ventilator-associated pneumonia is an important risk factor for mortality after major cardiac surgery.

Eduardo Tamayo1, Francisco Javier Álvarez, Beatriz Martínez-Rafael, Juan Bustamante, Jesus F Bermejo-Martin, Inma Fierro, Jose Maria Eiros, Javier Castrodeza, Maria Heredia, José I Gómez-Herreras.   

Abstract

PURPOSE: Ventilator-associated pneumonia (VAP) is the main infectious complication in cardiac surgery patients and is associated with an important increase in morbidity and mortality. The aim of our study was to analyze the impact of VAP on mortality excluding other comorbidities and to study its etiology and the risk factors for its development.
MATERIALS AND METHODS: This prospective cohort study included 1610 postoperative cardiac surgery patients' status post cardiopulmonary bypass (CPB) between July 2004 and January 2008. The primary outcome measures were the development of VAP and in-hospital mortality.
RESULTS: Ventilator-associated pneumonia was observed in 124 patients (7.7%). Patients with VAP had a longer length of hospitalization (40.7 ± 35.1 vs 16.1 ± 30.1 days, P < .0001) and greater in-hospital mortality (49.2% [61/124] vs 2.0% [30/1486], P = .0001) in comparison with patients without VAP. After performing the Cox multivariant analysis adjustment, VAP was identified as the most important independent mortality risk factor (adjusted hazard ratio [HR], 8.53; 95% confidence interval, 4.21-17.30; P = .0001). Other independent risk factors of in-hospital mortality were chronic renal failure (HR, 2.56), diabetes mellitus (HR, 1.90), CPB time (HR, 1.51), respiratory failure (HR, 2.13), acute renal failure (HR, 2.39), and mediastinal bleeding of at least 1000 mL (HR, 1.81).
CONCLUSIONS: The development of VAP after CPB is the most important independent risk factor for in-hospital mortality. Identification of effective strategies for the prevention of VAP is needed.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21596516     DOI: 10.1016/j.jcrc.2011.03.008

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  16 in total

Review 1.  Infectious complications of cardiac surgery: a clinical review.

Authors:  Matthew E Cove; Denis W Spelman; Graeme MacLaren
Journal:  J Cardiothorac Vasc Anesth       Date:  2012-07-04       Impact factor: 2.628

Review 2.  Pneumonia After Cardiovascular Surgery: Incidence, Risk Factors and Interventions.

Authors:  Dashuai Wang; Yang Lu; Manda Sun; Xiaofan Huang; Xinling Du; Zhouyang Jiao; Fuqiang Sun; Fei Xie
Journal:  Front Cardiovasc Med       Date:  2022-06-30

3.  The role of Octenidol(®), Glandomed(®) and chlorhexidine mouthwash in the prevention of mucositis and in the reduction of the oropharyngeal flora: a double-blind randomized controlled trial.

Authors:  Nico T Mutters; Thomas R Neubert; Rudolf Nieth; Reinier Mutters
Journal:  GMS Hyg Infect Control       Date:  2015-02-13

4.  Procalcitonin as a diagnostic marker of ventilator-associated pneumonia in cardiac surgery patients.

Authors:  Jia Jiao; Min Wang; Jianfeng Zhang; Kangjun Shen; Xiaobo Liao; Xinmin Zhou
Journal:  Exp Ther Med       Date:  2015-01-09       Impact factor: 2.447

5.  Influence of Remifentanil/Propofol Anesthesia on Ventilator-associated Pneumonia Occurence After Major Cardiac Surgery.

Authors:  Alisa Krdzalic; Anita Kosjerina; Elmir Jahic; Zijah Rifatbegovic; Goran Krdzalic
Journal:  Med Arch       Date:  2013-12-28

6.  Pneumonia after Major Cancer Surgery: Temporal Trends and Patterns of Care.

Authors:  Vincent Q Trinh; Praful Ravi; Abd-El-Rahman M Abd-El-Barr; Jay K Jhaveri; Mai-Kim Gervais; Christian P Meyer; Julian Hanske; Jesse D Sammon; Quoc-Dien Trinh
Journal:  Can Respir J       Date:  2016-05-31       Impact factor: 2.409

7.  Plasma and Lung Tissue Pharmacokinetics of Ceftaroline Fosamil in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass: an In Vivo Microdialysis Study.

Authors:  M Edlinger-Stanger; V Al Jalali; M Andreas; W Jäger; M Böhmdorfer; M Zeitlinger; D Hutschala
Journal:  Antimicrob Agents Chemother       Date:  2021-07-19       Impact factor: 5.191

8.  Impact of four sequential measures on the prevention of ventilator-associated pneumonia in cardiac surgery patients.

Authors:  María Jesús Pérez-Granda; José María Barrio; Patricia Muñoz; Javier Hortal; Cristina Rincón; Emilio Bouza
Journal:  Crit Care       Date:  2014-03-26       Impact factor: 9.097

9.  Impact of ventilator-associated pneumonia on mortality and epidemiological features of patients with secondary peritonitis.

Authors:  María Heredia-Rodríguez; María Teresa Peláez; Inmaculada Fierro; Esther Gómez-Sánchez; Estefanía Gómez-Pesquera; Mario Lorenzo; F Javier Álvarez-González; Juan Bustamante-Munguira; José María Eiros; Jesús F Bermejo-Martin; José I Gómez-Herreras; Eduardo Tamayo
Journal:  Ann Intensive Care       Date:  2016-04-18       Impact factor: 6.925

10.  World-wide variation in incidence of Acinetobacter associated ventilator associated pneumonia: a meta-regression.

Authors:  James C Hurley
Journal:  BMC Infect Dis       Date:  2016-10-18       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.